Main Industry
Health Care
Main Product/Service
Collagen Solution
3D Collagen Printing Gel (3D ColLive Gel)
Non-recombinant Porous Collagen Matrix (nPCM)
Regenerative Medicine Dermis (RegDerm)
Collagen and Related Derivative Product Technical Services
3D Collagen Printing Gel (3D ColLive Gel)
Non-recombinant Porous Collagen Matrix (nPCM)
Regenerative Medicine Dermis (RegDerm)
Collagen and Related Derivative Product Technical Services
Founded Year
2022
Unified Business No.
90401152
Status
Active
Number of Employees
0
Total Paid-in
Capital
39,569,000 (NT$)
Location of Company
Taiwan
, Tainan City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
FM&G Biomed is engaged in the research, development, manufacturing, technical services, and derivative applications of medical materials such as collagen. Using its internationally patented extraction and purification technology for the unique Non-recombinant Porous Collagen Matrix (nPCM), the company preserves the high strength of natural collagen fibers and the uniform pore structure of the matrix, with no chemical residues and excellent biocompatibility. Additionally, its patented extraction and purification technology produces high-purity, high-concentration collagen solutions that are antigen-removed while maintaining the intact molecular structure of collagen. Key superior materials from these two core technologies give rise to products such as regenerative dermis and bone/dental fillers, 3D printable ColLive gel, and cell therapy products, meeting the needs of regenerative medicine, wound care, tissue engineering, and medical aesthetics.
